Skip to main content

Certara Reports Third Quarter 2025 Financial Results

Updates Full Year 2025 Financial Guidance RADNOR, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal year 2025. Third Quarter Highlights:Revenue was $104.6 million, compared to $94.8 million in the third quarter of 2024, representing growth of 10%.Software revenue was $43.8 million, compared to $35.9 million in the third quarter of 2024, representing growth of 22%. Services revenue was $60.8 million, compared to $58.9 million in the third quarter of 2024, representing growth of 3%.Net income was $1.5 million, compared to a net loss of $1.4 million in the third quarter of 2024, representing growth of 211%. Adjusted EBITDA was $35.2 million, compared to $33.1 million in the third quarter...

Continue reading

Farmer Brothers Coffee Reports First Quarter Fiscal 2026 Financial Results

Gross margin decreased 400 basis points year-over-year to 39.7%Reported net loss of $4 million, adjusted EBITDA1 of $1.4 millionNet sales of $81.6 million FORT WORTH, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) — Farmer Brothers Coffee Co. (NASDAQ: FARM), a leading roaster, wholesaler and distributor of coffee, tea and allied products, announced today its first quarter fiscal 2026 financial results for the period ended Sept. 30, 2025. The company filed its Form 10-Q, which will be posted on the Investor Relations section of its website after the close of market on Thursday, Nov. 6. “Fiscal 2025 was a year of significant operational and financial improvement for Farmer Brothers. I am very pleased we were able to maintain the majority of that progress despite a very challenging economic environment during the first quarter,” said President...

Continue reading

vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Topline Phase 3 CATT1 data for cadisegliatin in type 1 diabetes expected second half 2026  $80 million private placement strengthens balance sheet and supports Phase 3 CATT1 completion Announced issuance of new U.S. patent covering crystalline salts and co-crystals forms of cadisegliatin with exclusivity expected out to 2041 HIGH POINT, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of type 1 diabetes (T1D), today reported financial results for the third quarter ended September 30, 2025, and provided an update on recent corporate developments. “The third quarter saw a series of meaningful achievements,” said Paul...

Continue reading

Kronos Worldwide, Inc. Reports Third Quarter 2025 Results

Dallas, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) — November 6, 2025…Kronos Worldwide, Inc. (NYSE:KRO) today reported a net loss of $37.0 million, or $.32 per share, in the third quarter of 2025 compared to net income of $71.8 million, or $.62 per share, in the third quarter of 2024. For the first nine months of 2025, Kronos Worldwide reported a net loss of $28.1 million, or $.24 per share, compared to net income of $99.4 million, or $.86 per share, in the first nine months of 2024. Net loss increased in the third quarter and first nine months of 2025 due to legislation enacted in Germany during the third quarter of 2025, which included a reduction of the corporate tax rate from 15% by one percentage point annually for five years, reaching 10% in 2032. As a result, we recorded a non-cash deferred income tax expense of $19.3 million...

Continue reading

Strawberry Fields REIT Announces Third Quarter 2025 Operating Results

SOUTH BEND, Ind., Nov. 06, 2025 (GLOBE NEWSWIRE) — Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) (the “Company”) reported today its operating results for the quarter ended September 30, 2025. FINANCIAL HIGHLIGHTS100% of contractual rents collected. On July 1, 2025, the Company completed the acquisition of nine skilled nursing facilities, comprised of 686 beds, located in Missouri. The acquisition was for $59,000,000 and the Company funded the acquisition utilizing working capital. Eight of the facilities were leased to the Tide Group and were added to their existing master lease that the Company entered into in August 2024. This acquisition increased Tide Group’s annual rents by $5.5 million and subject to 3% annual rent increases. The ninth facility was leased to an affiliate of Reliant Care Group L.L.C. The facility was...

Continue reading

eXp World Holdings Reports Q3 2025 Results

eXp World Holdings Reports Q3 2025 ResultseXp World Holdings Reports Q3 2025 ResultsBELLINGHAM, Wash., Nov. 06, 2025 (GLOBE NEWSWIRE) — eXp World Holdings, Inc. (Nasdaq: EXPI), or the “Company”, the holding company for eXp Realty®, FrameVR.io and SUCCESS® Enterprises, today announced financial results for the third quarter ended September 30, 2025. “Our third quarter results underscore the strength of eXp’s model and the power of our agents,” said Leo Pareja, CEO of eXp Realty. “Continued momentum in agent growth, productivity and retention are driving higher revenue, profitability and overall performance. Our agent-first culture, combined with ongoing innovation across the eXp platform, continues to attract and empower top agents and teams around the world. As we scale, our focus remains on delivering even greater value...

Continue reading

Palomar Holdings, Inc. Reports Third Quarter 2025 Results

LA JOLLA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or “Company”) reported net income of $51.5 million, or $1.87 per diluted share, for the third quarter of 2025 compared to net income of $30.5 million, or $1.15 per diluted share, for the third quarter of 2024. Adjusted net income(1) was $55.2 million, or $2.01 per diluted share, for the third quarter of 2025 as compared to $32.4 million, or $1.23 per diluted share, for the third quarter of 2024. Third Quarter 2025 HighlightsGross written premiums increased by 43.9% to $597.2 million compared to $415.0 million in the third quarter of 2024 Net income of $51.5 million compared to $30.5 million in the third quarter of 2024 Adjusted net income(1) increased 70.0% to $55.2 million compared to $32.4 million in the third quarter of 2024 Total...

Continue reading

Euronext publishes Q3 2025 results and announces a share repurchase programme

Euronext publishes Q3 2025 results and announces a share repurchase programme Euronext has delivered the sixth consecutive quarter of double-digit growth, driven by the expansion of non-volume-related businesses, resilient trading and clearing revenues and continued cost discipline. Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 6 November 2025 – Euronext, the leading European capital market infrastructure, today publishes its results for the third quarter of 2025.Q3 2025 revenue and income was up +10.6%1 to €438.1 million:Non-volume-related revenue and income represented 60% of total revenue and income and covered 162% of underlying operating expenses, excluding D&A2:Securities Services revenues grew to €77.3 million (+6.0%), driven by double-digit revenue growth in custody and settlement, supported by sustainable...

Continue reading

Akwel: Nine-month revenue down -3.6%

        Champfromier — Thursday, November 6, 2025 NINE-MONTH REVENUE DOWN -3.6% AKWEL (FR0000053027, AKW, PEA-eligible), parts and systems manufacturer for the automotive and heavy-vehicle industry, specialist in fluid management, mechanisms and structural parts for electric vehicles, has recorded, over the first 9 months of 2025, a published consolidated revenue of €730.7M. Consolidated revenue (from January 1 to September 30, 2025)in €m — unaudited 2025 2024 Variation PCC variation (1)1st quarter 255.6 263.5 -3.0% -4.0%2nd quarter 255.0 265.3 -3.9% -2.7%3rd quarter 220.1 228.9 -3.9% -2.0%Nine-month total 730.7 757.7 -3.6% -3.0%(1)   At constant scope and exchange rates. In the third quarter of the year, AKWEL recorded a decline in reported activity of -3.9%, which is comparable to previous quarters, and -2.0% at constant...

Continue reading

Akwel: Nine-Month Revenue Down -3.6%

        Champfromier — Thursday, November 6, 2025 NINE-MONTH REVENUE DOWN -3.6% AKWEL (FR0000053027, AKW, PEA-eligible), parts and systems manufacturer for the automotive and heavy-vehicle industry, specialist in fluid management, mechanisms and structural parts for electric vehicles, has recorded, over the first 9 months of 2025, a published consolidated revenue of €730.7M, down -3.6% compared to the same period in 2024. Consolidated revenue (from January 1 to September 30, 2025)in €m — unaudited 2025 2024 Variation PCC variation (1)1st quarter 255.6 263.5 -3.0% -4.0%2nd quarter 255.0 265.3 -3.9% -2.7%3rd quarter 220.1 228.9 -3.9% -2.0%Nine-month total 730.7 757.7 -3.6% -3.0%(1)   At constant scope and exchange rates. DECREASE OF -3.9% IN THIRD-QUARTER REVENUE With consolidated revenue of €220.1M in the third quarter...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.